These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15197938)

  • 1. [Anticoagulation for plasmapheresis].
    Amemiya H; Sekihara H; Kobayashi T; Koiwa F; Niikura K
    Nihon Rinsho; 2004 May; 62 Suppl 5():323-7. PubMed ID: 15197938
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in coagulation, fibrinolysis and platelet functions during extracorporeal circulation].
    Kaizu K; Uriu K; Ikeda M
    Nihon Rinsho; 2004 May; 62 Suppl 5():46-9. PubMed ID: 15197886
    [No Abstract]   [Full Text] [Related]  

  • 3. [How to use anticoagulants in hemodialysis therapy].
    Uriu K; Kaizu K
    Nihon Rinsho; 2004 May; 62 Suppl 5():163-7. PubMed ID: 15197908
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute renal failure - anticoagulation in continuous renal replacement therapy].
    Hein OV; Birnbaum J; Spies C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2008 Apr; 43(4):294-301; quiz 302. PubMed ID: 18409124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of anticoagulants for leukocytapheresis therapy in cases of active ulcerative colitis.
    Kanke K; Hoshino M; Tominaga K; Nakano M; Terano A; Hiraishi H
    Blood Purif; 2007; 25(4):370-6. PubMed ID: 17785966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anticoagulant].
    Mitome J; Yamamoto H
    Nihon Rinsho; 2004 May; 62 Suppl 5():368-73. PubMed ID: 15197947
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparins, antivitamins K. Principles and rules of use. Posology of non-fractionated heparins].
    Delsart D; Chambefort V; Decousus H
    Rev Prat; 2001 Sep; 51(13):1489-97. PubMed ID: 11601082
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A; Avalos C; Orellana G; Cifuentes C; Rivas J; Calderón F
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Strandness DE
    N Engl J Med; 1996 Aug; 335(9):670-1; author reply 671-2. PubMed ID: 8692246
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of venous thromboembolism after acute spinal cord injury with low-dose heparin or low-molecular-weight heparin.
    Paciaroni M; Ageno W; Agnelli G
    Thromb Haemost; 2008 May; 99(5):978-80. PubMed ID: 18449438
    [No Abstract]   [Full Text] [Related]  

  • 11. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis).
    Koracevic G
    Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712
    [No Abstract]   [Full Text] [Related]  

  • 12. Unfractionated versus low-molecular-weight heparin for deep venous thrombosis.
    Penner J
    N Engl J Med; 1996 Aug; 335(9):671; author reply 671-2. PubMed ID: 8692247
    [No Abstract]   [Full Text] [Related]  

  • 13. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Greaves M;
    Thromb Haemost; 2002 Jan; 87(1):163-4. PubMed ID: 11848446
    [No Abstract]   [Full Text] [Related]  

  • 14. [Low-molecular-weight heparin in deep venous thrombosis. Dosage for all weight classes].
    MMW Fortschr Med; 2003 Jun; 145(24):56. PubMed ID: 12866309
    [No Abstract]   [Full Text] [Related]  

  • 15. Preoperative low molecular weight heparin reduces heparin responsiveness during cardiac surgery.
    Bar-Yosef S; Cozart HB; Phillips-Bute B; Mathew JP; Grocott HP
    Can J Anaesth; 2007 Feb; 54(2):107-13. PubMed ID: 17272249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety assessment and pharmacodynamics of a novel ultra low molecular weight heparin (RO-14) in healthy volunteers--a first-time-in-human single ascending dose study.
    Rico S; Antonijoan RM; Gich I; Borrell M; Fontcuberta J; Monreal M; Martinez-Gonzalez J; Barbanoj MJ
    Thromb Res; 2011 Apr; 127(4):292-8. PubMed ID: 21257196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of various anticoagulant agents on large-volume leukocytapheresis using new Cellsorba CS-180S Filter.
    Hohtatsu K; Yamaji K; Yamada R; Oda K; Kageyama M; Kusaoi M; Onuma S; Kawamoto T; Sugimoto K; Sekiya F; Kon T; Ogasawara M; Kempe K; Tsuda H; Takasaki Y
    Ther Apher Dial; 2011 Aug; 15(4):355-9. PubMed ID: 21884469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrate anticoagulation and on-line cell washing in intraoperative autotransfusion in the baboon.
    Kingsley JR; Valeri CR; Peters H; Cole BC; Fouty WJ; Herman CM
    Surg Forum; 1973; 24():258-60. PubMed ID: 4806003
    [No Abstract]   [Full Text] [Related]  

  • 19. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring blood coagulation].
    Pabinger-Fasching I
    Wien Med Wochenschr; 1999; 149(2-4):70-1. PubMed ID: 10378328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.